Sales Vision Pharma CRM is a powerful strategic tool for sales/medical efficiency and helps to integrate marketing and sales in pharmaceutical companies. Sales Vision helps to manage medical representatives and KAM’s in pharmaceutical companies with more than 35 different pharmaceutical modules. Today we are one of the leading European Pharma CRM providers.
Progress means innovation. Innovation means thinking different. Our growth can be explained because our seek for innovate the pharmaceutical sales force effectiveness and marketing. As an example we have created the first native and offline iPhone Pharma CRM software. We also support and offer Sales Vision Pharma CRM as SAAS, cloud computing and on platforms such as web applications, PC offline versions, Windows pocket, mobile intelligence and iPhone version.
Our philosophy is to deliver a wide range of solutions with the Pharma CRM, like our e-testing solution ExpertVision, Sales Force effectiveness consulting, healthcare database, sales plans etc.
Our focus is to be a pharmaceutical partner in more than 30 countries and 26 different pharma companies. Sales Vision is a solution that was created to cover pharma needs, processes and trends. Pharmacentric since 1996.


Alkaloid Russia has implemented Sales Vision Win version for their medical reps to increase the sales force effectiveness, integrate pharma marketing/sales activities and manage the customer relationship management. The big sales force from Alkaloid Russia now will have better conditions to plan/organize their visits and to have a better flow of marketing/sales processes on the [...]

GlaxoSmithKlineMexico implements Sales Vision Anywhere as for sales force effectiveness of the marketing and sales processes. Sales Vision Pharma CRM on different platforms now becomes a new important and famous user.
“We know that Sales Vision is now a brand and synonym for pharma excellence and this fact many international pharmaceutical companies can identify as an [...]




Nycomed’s performance was driven by strong growth of Key Products and in most emerging markets. This overall positive performance could not fully offset the expected negative impact of pantoprazole’s patent expiry in Europe. Daxas® (roflumilast) is advancing well: Nycomed received a positive opinion from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human [...]

Bayer Schering Pharma AG, Germany, will establish a U.S. Innovation Center in San Francisco, Calif. with the goal to expand its global research network and build its specialty pharmaceutical pipeline.
The model introduces a newly formed “Science Hub” for innovation sourcing in the U.S. creating collaborations with academic research scientists and small biotech firms to realize [...]

